Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Obrecht

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Schweizerische Medizinische Wochenschrift|September 2, 1978
[Current state of therapy for gastrointestinal tumors]D Hartmann, J P Obrecht
Therapeutische Umschau. Revue Therapeutique|October 1, 1989
[Infusion pumps and subcutaneously implantable catheter systems as an aid in the ambulatory care of tumor patients]C U Ludwig, J P Obrecht
Schweizerische Medizinische Wochenschrift|May 29, 1976
[The so-called white Burkitt's lymphoma]D Hartmann, W Wegmann, J P Obrecht
International Journal of Immunopharmacology|January 1, 1986
Conjugation behaviour of different monoclonal antibodies to f-methionyl-leucyl-phenylalanineR Obrist, J Schmidli, J P Obrecht
Schweizerische Medizinische Wochenschrift|September 5, 1981
[Tumor stem cell cultures on agar: 1st results]C Ludwig, R Ludwig, J P Obrecht
Onkologie|October 1, 1987
[10 years' therapy of Hodgkin's disease in the Oncology Department of the Basel Canton Hospital: a retrospective study]M Battegay, R Obrist, J P Obrecht
Onkologie|June 1, 1988
Mediastinal Hodgkin's disease--a retrospective analysisR Obrist, M Battegay, J P Obrecht
MMW, Munchener Medizinische Wochenschrift|January 15, 1982
[The value of vitamin A and vitamin A derivatives (retinoids) in oncologic therapy]W Weber, D Hartmann, J P Obrecht
Schweizerische Medizinische Wochenschrift|May 31, 1980
[Epidemiology of pancreatic carcinoma in Basle]W Weber, J Torhorst, J P Obrecht
Biochemical and Biophysical Research Communications|September 30, 1988
Chemotactic monoclonal antibody conjugates: a comparison of four different f-Met-peptide-conjugatesR Obrist, J Schmidli, J P Obrecht
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Schweizerische Medizinische Wochenschrift|September 2, 1978
[Current state of therapy for gastrointestinal tumors]D Hartmann, J P Obrecht
Therapeutische Umschau. Revue Therapeutique|October 1, 1989
[Infusion pumps and subcutaneously implantable catheter systems as an aid in the ambulatory care of tumor patients]C U Ludwig, J P Obrecht
Schweizerische Medizinische Wochenschrift|May 29, 1976
[The so-called white Burkitt's lymphoma]D Hartmann, W Wegmann, J P Obrecht
International Journal of Immunopharmacology|January 1, 1986
Conjugation behaviour of different monoclonal antibodies to f-methionyl-leucyl-phenylalanineR Obrist, J Schmidli, J P Obrecht
Schweizerische Medizinische Wochenschrift|September 5, 1981
[Tumor stem cell cultures on agar: 1st results]C Ludwig, R Ludwig, J P Obrecht
Onkologie|October 1, 1987
[10 years' therapy of Hodgkin's disease in the Oncology Department of the Basel Canton Hospital: a retrospective study]M Battegay, R Obrist, J P Obrecht
Onkologie|June 1, 1988
Mediastinal Hodgkin's disease--a retrospective analysisR Obrist, M Battegay, J P Obrecht
MMW, Munchener Medizinische Wochenschrift|January 15, 1982
[The value of vitamin A and vitamin A derivatives (retinoids) in oncologic therapy]W Weber, D Hartmann, J P Obrecht
Schweizerische Medizinische Wochenschrift|May 31, 1980
[Epidemiology of pancreatic carcinoma in Basle]W Weber, J Torhorst, J P Obrecht
Biochemical and Biophysical Research Communications|September 30, 1988
Chemotactic monoclonal antibody conjugates: a comparison of four different f-Met-peptide-conjugatesR Obrist, J Schmidli, J P Obrecht
Pageof 13